Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox (Mpox) Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Catabolism of arginine: substrate supply
- Catabolism of arginine: the Krebs urea cycle
- Hepatocytes vs. macrophages
- Regulation of iNOS transcription
- Importance of iNOS in mycobacterial disease
- Structure of arginases
- Evidence for Arg1 regulation by Stat6 pathway
- The type I and II IL-4 and IL-13 receptors
- Mechanism of Arg1 regulation by Stat6 pathway
- Regulation of Arg1 by the Stat3 pathway
- Catabolism of arginine: Arg1 vs. iNOS
- The substrate depletion concept
- Norvaline
- Catabolism of arginine, separation of powers
- Arginases, NO and pathogenesis (1)
- Arginases, NO and pathogenesis (2)
- Arginase and in vivo regulation of NO
- Arginase and in vivo regulation of NO (2)
- Schistosome infection and Arg1(1)
- Schistosome infection and Arg1(2)
- Schistosome infection and AAMs
- Severe periportal fibrosis, genetic components (1)
- Severe periportal fibrosis, genetic components (2)
- Macrophage Arg1 is essential for T cell response
- What about macrophage Arg1 in asthma?
- Arginase inhibitors
- Arginase & NO: unresolved questions
- Thank you
Topics Covered
- Catabolism of arginine to downstream substrates
- Catabolism of arginine in macrophages
- Nitric oxide production
- Control of iNOS at the transcriptional level
- Role of nitric oxide in immunity to intracellular pathogens with a focus on mycobacterial disease
- Structure of arginases
- Transcriptional control of arginase 1 in the liver vs. macrophages
- Arginases can suppress nitric oxide production by substrate depletion
- Pathogens use many mechanisms to regulate nitric oxide
- Arginases and alternatively-activated macrophages (AAMs)
- Schistosome infection as an example of AAM function
- AAMs and arginases
- Arginase inhibition by small molecules
- Outstanding questions
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Murray, P. (2011, August 31). Arginase and nitric oxide [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 21, 2024, from https://doi.org/10.69645/ZPMW3102.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Peter Murray has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.